Voloridge Investment Management, LLC Ultragenyx Pharmaceutical Inc. Transaction History

Voloridge Investment Management, LLC

$26.2 Billion
Q3 2024

A detailed history of Voloridge Investment Management, LLC transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Voloridge Investment Management, LLC holds 52,266 shares of RARE stock, worth $2.49 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

52,266

Holding current value

$2.49 Million

% of portfolio

0.01%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$40.21 - $59.36 $2.1 Million - $3.1 Million	52,266 New	52,266 $2.9 Million
Q2 2023 Aug 14, 2023	SELL	$37.35 - $52.15 $3.79 Million - $5.29 Million	-101,447 Reduced 84.21%	19,027 $877,000
Q1 2023 May 15, 2023	BUY	$36.99 - $48.71 $1.28 Million - $1.69 Million	34,640 Added 40.36%	120,474 $4.83 Million
Q4 2022 Feb 14, 2023	BUY	$33.72 - $46.33 $2.3 Million - $3.16 Million	68,139 Added 385.07%	85,834 $3.98 Million
Q3 2022 Nov 14, 2022	BUY	$39.96 - $66.14 $707,092 - $1.17 Million	17,695 New	17,695 $733,000
Q2 2022 Aug 15, 2022	SELL	$45.8 - $85.4 $1.2 Million - $2.25 Million	-26,295 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$62.2 - $84.4 $1.34 Million - $1.82 Million	-21,521 Reduced 45.01%	26,295 $1.91 Million
Q4 2021 Feb 14, 2022	BUY	$73.71 - $87.86 $2.66 Million - $3.17 Million	36,062 Added 306.81%	47,816 $4.02 Million
Q3 2021 Nov 15, 2021	SELL	$77.92 - $102.4 $1.3 Million - $1.71 Million	-16,702 Reduced 58.69%	11,754 $1.06 Million
Q2 2021 Aug 16, 2021	BUY	$92.19 - $115.71 $2.2 Million - $2.76 Million	23,854 Added 518.34%	28,456 $2.71 Million
Q1 2021 May 17, 2021	SELL	$106.9 - $167.73 $746,482 - $1.17 Million	-6,983 Reduced 60.28%	4,602 $524,000
Q4 2020 Feb 16, 2021	BUY	$84.4 - $177.39 $76,297 - $160,360	904 Added 8.46%	11,585 $1.6 Million
Q3 2020 Nov 16, 2020	BUY	$72.98 - $90.0 $779,499 - $961,290	10,681 New	10,681 $878,000
Q1 2020 May 15, 2020	SELL	$33.8 - $62.9 $731,262 - $1.36 Million	-21,635 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$36.08 - $45.83 $780,590 - $991,532	21,635 New	21,635 $924,000
Q3 2018 Nov 14, 2018	SELL	$71.81 - $90.15 $1.33 Million - $1.67 Million	-18,470 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$48.54 - $85.31 $896,533 - $1.58 Million	18,470 New	18,470 $1.42 Million

Others Institutions Holding RARE

# of Institutions

325

Shares Held

85.7M

Call Options Held

520K

Put Options Held

406K

View Full List

About Ultragenyx Pharmaceutical Inc.

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $3.34B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

More about RARE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voloridge Investment Management, LLC with notifications on news.

Account

Voloridge Investment Management, LLC Ultragenyx Pharmaceutical Inc. Transaction History